Big Pharma hopes research spending—not reasonable pricing—will improve image

Enlarge (credit: Getty | BSIP) The current optics of the pharmaceutical industry are rather unpleasant. Drug prices continue to skyrocket, pharmaceutical executives have reported salaries in the tens of millions, and communities across the country are devastated by the opioid epidemic, which was sparked by drug makers who criminally misled regulators, doctors, and patients about […]